Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132297) titled 'Efficacy and Safety of Intermittent Sublingual Administration of Low-dose Nifedipine Pills for Antihypertensive Treatment in Patients with Hypertensive Urgency: A Multicenter, Randomized, Positive-drug Parallel-controlled Pragmatic Clinical Study' on Sept. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Hypertensive urgency
Intervention:
Intervention Group 2 (Standard Antihypertensive Group):Blood pressure reduction target: The blood pressure should be reduced to below 180/110 mmHg. Nifedipine pellets are taken sublingually at a...